UNLIMITED TURBO SHORT - STAAR SURGICAL Share Price

Certificat

DE000PC86FK6

Market Closed - Börse Stuttgart 20:42:56 31/05/2024 BST
0.69 EUR -10.39% Intraday chart for UNLIMITED TURBO SHORT - STAAR SURGICAL
Date Price Change
31/05/24 0.69 -10.39%
30/05/24 0.77 -4.94%
29/05/24 0.81 +10.96%
28/05/24 0.73 +4.29%
27/05/24 0.7 -.--%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 08:42 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STAAR SURGICAL COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC86FK
ISINDE000PC86FK6
Date issued 02/05/2024
Strike 48.05 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.83
Lowest since issue 0.21

Company Profile

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Sector
-
More about the company

Ratings for STAAR Surgical Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: STAAR Surgical Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
41.53 USD
Average target price
52.31 USD
Spread / Average Target
+25.96%
Consensus